FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharma Global Fze buPROPion Hydrochloride Extended-¿release Recall

buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-Day, Rx On…

Sun Pharma Global Fze

Risk level
Class III
Reported by FDA
Aug 26, 2015
Recall ID
D-1345-2015
Check your lot numberHow we source this data

Summary

Sun Pharma Global Fze recalled buPROPion Hydrochloride Extended-¿release starting Jul 17, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1345-2015 on Aug 26, 2015. Reason: Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.

Product description

buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-Day, Rx Only, 60 count Bottle, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, Manufactured By: Sun Pharmaceutical Ind. Ltd., Halol Baroda Highway, Halol 389 350, Gujarat, India, NDC 47335-738-86

Lot numbers, UPCs & expiration codes

Lot #s: JKM4152A, JKM4737A, JKM5270A, Exp 08/2015

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1345-2015
Classification
Class III
Status
Terminated
Recall initiated
Jul 17, 2015
FDA report date
Aug 26, 2015
Quantity
35,235 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharma Global Fze

Original FDA data

Every field from FDA enforcement report D-1345-2015, exactly as published.

Show all FDA fields
City
Sharm
Status
Terminated
Country
United Arab Emirates
Event ID
71949
Address
Office # 43 Block Y Saif Zone
Code information
Lot #s: JKM4152A, JKM4737A, JKM5270A, Exp 08/2015
Report date
Aug 26, 2015
Product type
Drugs
Recall number
D-1345-2015
Classification
Class III
Recalling firm
Sun Pharma Global Fze
Product quantity
35,235 bottles
Termination date
Mar 22, 2016
Reason for recall
Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.
Voluntary / mandated
Voluntary: Firm initiated
Product description
buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-Day, Rx Only, 60 count Bottle, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, Manufactured By: Sun Pharmaceutical Ind. Ltd., Halol Baroda Highway, Halol 389 350, Gujarat, India, NDC 47335-738-86
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Jul 17, 2015
Initial firm notification
Letter
Center classification date
Aug 14, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1345-2015, published Aug 26, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls